We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.
Gene namei
Official gene symbol, which is typically a short form of the gene name, according to HGNC.
All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.
Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.
Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).
The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.
Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.
Chromosome
11
Cytoband
q13.1
Chromosome location (bp)
64269830 - 64284704
Number of transcriptsi
Number of protein-coding transcripts from the gene as defined by Ensembl.
The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).
In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl
The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.
At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.
Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).
The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).
If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.
Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
BAD-201
BAD-202
BAD-203
BAD-204
BAD-205
BAD-207
PROTEIN INFORMATIONi
The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.
The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.
The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.
The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Q92934 [Direct mapping] Bcl2-associated agonist of cell death A0A024R562 [Target identity:100%; Query identity:100%] BCL2-antagonist of cell death, isoform CRA_c
Show all
Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC RAS pathway related proteins Cancer-related genes Candidate cancer biomarkers Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001836 [release of cytochrome c from mitochondria] GO:0001844 [protein insertion into mitochondrial membrane involved in apoptotic signaling pathway] GO:0005515 [protein binding] GO:0005543 [phospholipid binding] GO:0005737 [cytoplasm] GO:0005739 [mitochondrion] GO:0005741 [mitochondrial outer membrane] GO:0005829 [cytosol] GO:0006915 [apoptotic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0008289 [lipid binding] GO:0008656 [cysteine-type endopeptidase activator activity involved in apoptotic process] GO:0010508 [positive regulation of autophagy] GO:0010918 [positive regulation of mitochondrial membrane potential] GO:0016020 [membrane] GO:0019901 [protein kinase binding] GO:0019903 [protein phosphatase binding] GO:0032024 [positive regulation of insulin secretion] GO:0033133 [positive regulation of glucokinase activity] GO:0042593 [glucose homeostasis] GO:0043065 [positive regulation of apoptotic process] GO:0043280 [positive regulation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0044342 [type B pancreatic cell proliferation] GO:0045862 [positive regulation of proteolysis] GO:0046031 [ADP metabolic process] GO:0046034 [ATP metabolic process] GO:0046902 [regulation of mitochondrial membrane permeability] GO:0046931 [pore complex assembly] GO:0050679 [positive regulation of epithelial cell proliferation] GO:0071260 [cellular response to mechanical stimulus] GO:0071316 [cellular response to nicotine] GO:0071456 [cellular response to hypoxia] GO:0090200 [positive regulation of release of cytochrome c from mitochondria] GO:0097191 [extrinsic apoptotic signaling pathway] GO:0097193 [intrinsic apoptotic signaling pathway] GO:0097202 [activation of cysteine-type endopeptidase activity] GO:1900740 [positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway] GO:2000078 [positive regulation of type B pancreatic cell development] GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
Q92934 [Direct mapping] Bcl2-associated agonist of cell death A0A024R562 [Target identity:100%; Query identity:100%] BCL2-antagonist of cell death, isoform CRA_c
Show all
Predicted intracellular proteins Intracellular proteins predicted by MDM and MDSEC RAS pathway related proteins Cancer-related genes Candidate cancer biomarkers Mapped to neXtProt neXtProt - Evidence at protein level Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0001666 [response to hypoxia] GO:0001836 [release of cytochrome c from mitochondria] GO:0001844 [protein insertion into mitochondrial membrane involved in apoptotic signaling pathway] GO:0005515 [protein binding] GO:0005543 [phospholipid binding] GO:0005737 [cytoplasm] GO:0005739 [mitochondrion] GO:0005741 [mitochondrial outer membrane] GO:0005829 [cytosol] GO:0006007 [glucose catabolic process] GO:0006915 [apoptotic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007283 [spermatogenesis] GO:0008283 [cell population proliferation] GO:0008289 [lipid binding] GO:0008625 [extrinsic apoptotic signaling pathway via death domain receptors] GO:0008630 [intrinsic apoptotic signaling pathway in response to DNA damage] GO:0008656 [cysteine-type endopeptidase activator activity involved in apoptotic process] GO:0009725 [response to hormone] GO:0009749 [response to glucose] GO:0010033 [response to organic substance] GO:0010508 [positive regulation of autophagy] GO:0010918 [positive regulation of mitochondrial membrane potential] GO:0014070 [response to organic cyclic compound] GO:0016020 [membrane] GO:0019050 [suppression by virus of host apoptotic process] GO:0019221 [cytokine-mediated signaling pathway] GO:0019901 [protein kinase binding] GO:0019903 [protein phosphatase binding] GO:0021987 [cerebral cortex development] GO:0030346 [protein phosphatase 2B binding] GO:0032024 [positive regulation of insulin secretion] GO:0032355 [response to estradiol] GO:0032570 [response to progesterone] GO:0033133 [positive regulation of glucokinase activity] GO:0033574 [response to testosterone] GO:0034201 [response to oleic acid] GO:0035774 [positive regulation of insulin secretion involved in cellular response to glucose stimulus] GO:0042493 [response to drug] GO:0042542 [response to hydrogen peroxide] GO:0042593 [glucose homeostasis] GO:0042981 [regulation of apoptotic process] GO:0043065 [positive regulation of apoptotic process] GO:0043200 [response to amino acid] GO:0043280 [positive regulation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0043281 [regulation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0043422 [protein kinase B binding] GO:0044342 [type B pancreatic cell proliferation] GO:0045471 [response to ethanol] GO:0045579 [positive regulation of B cell differentiation] GO:0045582 [positive regulation of T cell differentiation] GO:0045862 [positive regulation of proteolysis] GO:0046031 [ADP metabolic process] GO:0046034 [ATP metabolic process] GO:0046902 [regulation of mitochondrial membrane permeability] GO:0046931 [pore complex assembly] GO:0050679 [positive regulation of epithelial cell proliferation] GO:0051384 [response to glucocorticoid] GO:0051592 [response to calcium ion] GO:0060139 [positive regulation of apoptotic process by virus] GO:0071247 [cellular response to chromate] GO:0071260 [cellular response to mechanical stimulus] GO:0071316 [cellular response to nicotine] GO:0071396 [cellular response to lipid] GO:0071456 [cellular response to hypoxia] GO:0071889 [14-3-3 protein binding] GO:0090200 [positive regulation of release of cytochrome c from mitochondria] GO:0097190 [apoptotic signaling pathway] GO:0097191 [extrinsic apoptotic signaling pathway] GO:0097192 [extrinsic apoptotic signaling pathway in absence of ligand] GO:0097193 [intrinsic apoptotic signaling pathway] GO:0097202 [activation of cysteine-type endopeptidase activity] GO:1900740 [positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway] GO:1901216 [positive regulation of neuron death] GO:1901423 [response to benzene] GO:1902220 [positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress] GO:1904710 [positive regulation of granulosa cell apoptotic process] GO:2000078 [positive regulation of type B pancreatic cell development] GO:2001244 [positive regulation of intrinsic apoptotic signaling pathway]
The Human Protein Atlas project is funded
